tiprankstipranks
Trending News
More News >
Kissei Pharmaceutical Co Ltd (KSPHF)
OTHER OTC:KSPHF
US Market

Kissei Pharmaceutical Co (KSPHF) Financial Statements

Compare
11 Followers

Kissei Pharmaceutical Co Financial Overview

Kissei Pharmaceutical Co's market cap is currently $1.23B. The company's EPS TTM is $0.4985218800000001; its P/E ratio is 11.72; and it has a dividend yield of 2.74%. Kissei Pharmaceutical Co is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 88.33B¥ 75.58B¥ 67.49B¥ 65.38B¥ 69.04B
Gross Profit¥ 44.06B¥ 37.34B¥ 32.38B¥ 31.24B¥ 32.72B
Operating Income¥ 5.77B¥ 4.02B¥ -1.13B¥ -1.40B¥ 1.50B
EBITDA¥ 20.25B¥ 18.72B¥ 17.81B¥ 20.26B¥ 10.65B
Net Income¥ 11.96B¥ 11.16B¥ 10.53B¥ 12.92B¥ 5.29B
Balance Sheet
Cash & Short-Term Investments¥ 48.65B¥ 45.93B¥ 49.60B¥ 53.15B¥ 44.45B
Total Assets¥ 244.06B¥ 260.93B¥ 221.20B¥ 238.09B¥ 268.86B
Total Debt¥ 1.28B¥ 1.34B¥ 1.49B¥ 1.64B¥ 1.74B
Net Debt¥ -23.89B¥ -21.55B¥ -24.40B¥ -28.37B¥ -18.71B
Total Liabilities¥ 33.93B¥ 39.80B¥ 26.39B¥ 35.91B¥ 48.91B
Stockholders' Equity¥ 209.00B¥ 220.03B¥ 193.90B¥ 201.38B¥ 219.31B
Cash Flow
Free Cash Flow¥ 2.01B¥ -3.51B¥ -9.23B¥ -386.00M¥ -4.03B
Operating Cash Flow¥ 6.52B¥ -1.68B¥ -6.68B¥ 1.53B¥ -2.54B
Investing Cash Flow¥ 4.95B¥ 8.69B¥ 6.00B¥ 10.78B¥ -9.33B
Financing Cash Flow¥ -9.32B¥ -10.01B¥ -3.42B¥ -2.76B¥ -4.00B
Currency in JPY

Kissei Pharmaceutical Co Earnings and Revenue History

Kissei Pharmaceutical Co Debt to Assets

Kissei Pharmaceutical Co Cash Flow

Kissei Pharmaceutical Co Forecast EPS vs Actual EPS